Concepedia

Author

Liteng Shen

Zhejiang University

Also Known As

Liteng Shen

18

Publications

215

Citations

8

H-Index

5

Concepts

All Affiliations

Zhejiang UniversityZhejiang LabSecond Affiliated Hospital of Zhejiang UniversityChinese Academy of SciencesHangzhou First People's Hospital
LS

About

Liteng Shen is an author at Zhejiang University specializing in drug discovery, cancer research, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

13

2

Biomolecular Engineering

1

1

13

3

Pharmacology

1

1

13

4

Drug Discovery

1

1

13

5

Cancer Research

1

1

13

Liteng Shen

×

8

Publications

188

Citations

8

H-Index

YearCitations

ADCdb: the database of antibody–drug conjugates

Liteng Shen, Xiuna Sun, Zhen Chen,

Nucleic Acids Research

2023

61

TransFoxMol: predicting molecular property with focused attention

Jian Gao, Zheyuan Shen, Yufeng Xie,

Briefings in Bioinformatics

2023

36

Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors

Yu Guo, Zheyuan Shen, Wenbin Zhao,

Advanced Science

2024

30

Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors

Haiting Duan, Jingyu Zhang, Renzhao Gui,

Journal of Medicinal Chemistry

2024

15

Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia

Jingyu Zhang, Haiting Duan, Renzhao Gui,

European Journal of Medicinal Chemistry

2023

13

Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening

Chenpeng Yao, Zheyuan Shen, Liteng Shen,

Pharmaceuticals

2023

12

Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers

Lu Yang, Zexu Shen, Yaping Xu,

Journal of Medicinal Chemistry

2024

11

Discovery of 2-Aminopyrimidine Derivatives as Potent Dual FLT3/CHK1 Inhibitors with Significantly Reduced hERG Inhibitory Activities

Xuemei Li, Peipei Wang, Chang Wang,

Journal of Medicinal Chemistry

2023

10

Page 1